Family Practice NewsPhysicians urged to write indications on drug scripts as methotrexate users face new barriers with SCOTUS decisionJuly 13, 2022RheumatologyWomen's HealthMixed Topics
Family Practice NewsFDA approves combination pegloticase and methotrexate for refractory gout July 12, 2022Rheumatology
Family Practice NewsZoster vaccination does not appear to increase flare risk in patients with immune-mediated inflammatory diseaseJuly 11, 2022Infectious DiseasesVaccinesRheumatologyDermatologyGastroenterology
Family Practice NewsLarge study reaffirms rare risk of TNF inhibitor–induced psoriasis in patients with RA, IBDJuly 11, 2022DermatologyRheumatologyMixed Topics
Family Practice NewsHydroxychloroquine risk found in some older patients with RAJune 28, 2022RheumatologyCardiology
Family Practice NewsOsteoporosis risk rises with air pollution levelsJune 21, 2022RheumatologyEndocrinology
Family Practice NewsBimekizumab calms psoriatic arthritis in phase 3 ‘BE’ trialsJune 15, 2022Rheumatology
Family Practice NewsNew onset-depression after RA diagnosis raises mortality risk ‘more than sixfold’June 15, 2022RheumatologyMental Health
Family Practice NewsBimekizumab tames active ankylosing spondylitis in BE MOBILE 2June 10, 2022Rheumatology
Family Practice NewsImmunosuppressed rheumatic patients not at high risk of breakthrough COVID-19June 7, 2022COVID-19 UpdatesRheumatology
Family Practice NewsMethotrexate enhances pegloticase response in uncontrolled goutJune 7, 2022Rheumatology
Family Practice NewsHigh maternal, fetal morbidity rates in SLE pregnanciesJune 3, 2022RheumatologyWomen's Health
